Astellas Pharma (4503N) Q1 2024 Earnings Report
MX:4503N Q1 2024 EPS Results
- Actual EPS
- MXN 2.50
- Consensus EPS
- MXN 1.14
- Beat/Miss
- Beat by +MXN 1.36
- One Year Ago EPS
- MXN 2.20
MX:4503N Q1 2024 Revenue Results
- Actual Revenue
- MXN 56.41B
- Expected Revenue
- MXN 49.14B
- Beat/Miss
- Beat by +MXN 7.27B
- YoY Revenue Growth
- +26.17%
Earnings Announcement Details
- Quarter
- Q1 2024
- Date
- 08/01/2024
- Time
- Before Open
- Conference Call
- Thursday, August 1, 2024
MX:4503N Upcoming Earnings
Astellas Pharma's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q1 2024 Earnings Call Audio
MX:4503N Q1 2024 Earnings Call
0:00 / 0:00
Q1 2024 Earnings Slide Deck
Q1 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4503N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q2) | 7.75- | 5.27 | ― | ― |
| Aug 05, 2026 | 2026 (Q1) | 6.459.44 | 4.56 | 107.09% (+4.88) | |
| Apr 27, 2026 | 2025 (Q4) | 3.652.90 | 4.99 | -41.95% (-2.09) | |
| Feb 04, 2026 | 2025 (Q3) | 5.486.68 | -6.5 | 202.73% (+13.19) | |
| Oct 30, 2025 | 2025 (Q2) | 3.555.27 | 2.39 | 120.44% (+2.88) | |
| Jul 30, 2025 | 2025 (Q1) | 2.374.56 | 2.5 | 82.00% (+2.05) | |
| Apr 25, 2025 | 2024 (Q4) | 2.544.99 | -2.21 | 325.50% (+7.20) | |
| Feb 04, 2025 | 2024 (Q3) | 2.92-6.50 | 1.24 | -624.52% (-7.74) | |
| Oct 30, 2024 | 2024 (Q2) | 2.152.39 | -0.1 | 2607.50% (+2.49) | |
| Aug 01, 2024 | 2024 (Q1) | 1.142.50 | 2.2 | 13.76% (+0.30) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
